Cargando…
Changes in DNA 5-Hydroxymethylcytosine Levels and the Underlying Mechanism in Non-functioning Pituitary Adenomas
Epigenetic factors have been proven to contribute to pituitary adenoma formation. 5-hydroxymethylcytosine (5hmC), which is catalyzed by ten-eleven translocation 2 (TET2), is related to DNA demethylation. In order to explore the pathogenesis of non-functioning pituitary adenomas (NFPAs), we detected...
Autores principales: | Xu, Yiwen, Niu, Yamei, Deng, Kan, Pan, Hui, Feng, Feng, Gong, Fengying, Tong, Wei-Min, Chen, Shi, Lu, Lin, Wang, Renzhi, You, Hui, Yao, Yong, Zhu, Huijuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381329/ https://www.ncbi.nlm.nih.gov/pubmed/32774324 http://dx.doi.org/10.3389/fendo.2020.00361 |
Ejemplares similares
-
Expression of EGFR in Pituitary Corticotroph Adenomas and Its Relationship With Tumor Behavior
por: Liu, Xiaohai, et al.
Publicado: (2019) -
Combination of transsphenoidal endoscopic surgery and presurgical somatostatin analogs in thyrotropin (TSH)-secreting pituitary adenomas: Treatment outcome and long-term remission at a single pituitary center
por: Liu, Jie, et al.
Publicado: (2022) -
The Treatment of Refractory Pituitary Adenomas
por: Dai, Congxin, et al.
Publicado: (2019) -
Clinical features and therapeutic outcomes of GH/TSH cosecreting pituitary adenomas: experience of a single pituitary center
por: Yu, Na, et al.
Publicado: (2023) -
Clinical and Therapeutic Characteristics of Pituitary TSH-Secreting Adenoma in Adolescent-Onset Patients: Six Case Studies and Literature Review
por: Yang, Yamei, et al.
Publicado: (2021)